Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Pancreatic Neoplasms 2Squamous Intraepithelial Lesions 1Squamous Cell Carcinoma of Head and Neck 1Skin Neoplasms 1Prostatic Neoplasms 1Pancreatic Adenocarcinoma Locally Advanced 1Neoplasm Metastasis 1Melanoma 1Kidney Neoplasms 1Head and Neck Neoplasms 1HIV Seropositivity 1Gynecological Cancers 1Colorectal Neoplasms 1Colorectal Liver Metastases 1Carcinoma, Hepatocellular 1

Interventions

Vincristine 1VGX-3100 1Rituximab 1Prednisone 1Etoposide 1Electroporation Therapies 1Electroporation 1Drug Therapy 1Doxorubicin 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × HIV Seropositivity × Electroporation × Clear all
NCT03603808 2026-05-08

VGX-3100 and Electroporation in Treating Patients With HIV-Positive High-Grade Anal Lesions

AIDS Malignancy Consortium

Phase 2 Completed
44 enrolled 15 charts
Gynecologic

Squamous Intraepithelial Lesions, HIV Seropositivity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡